The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
Trending
- With AI and biomarkers, selfies could support doctors’ decision-making (Healthcare IT News)
- AI-Based Ambient Scribes May Reduce Physician Documentation Time, Burnout (Gastroenterology Advisor)
- ChatGPT’s AI Health-Care Push Has a Fatal Flaw (Bloomberg)
- Exploring trust factors in AI-healthcare integration: a rapid review (Frontiers in Artficial Intelligence)
- ChatGPT’s AI Health-Care Push Has a Fatal Flaw (Bloomberg)
- AI is speeding into healthcare. Who should regulate it? (The Harvard Gazette)
- Ethical and Legal Considerations for Responsible Use of AI in Clinical Gastroenterology (American Journal of Gastroenterology)
- Google Launches MedGemma 1.5 & MedASR to Broaden Healthcare AI Capabilities (Digital Health News)
